» Articles » PMID: 6772562

Production of Mucoid Microcolonies by Pseudomonas Aeruginosa Within Infected Lungs in Cystic Fibrosis

Overview
Journal Infect Immun
Date 1980 May 1
PMID 6772562
Citations 237
Authors
Affiliations
Soon will be listed here.
Abstract

Direct electron microscopic examination of postmortem lung material from cystic fibrosis patients infected with Pseudomonas aeruginosa has shown that these bacterial cells form distinct fiber-enclosed microcolonies in the infected alveoli. Similar examination of bronchoscopy material from infected cystic fibrosis patients showed that the fibres of the enveloping matrix are definitely associated with the bacterial cells. The fibers of the extracellular matrix stain with ruthenium red and are therefore presumed to be polyanionic. When mucoid strains of P. aeruginosa were recovered from cystic fibrosis patients and grown in a suitable liquid medium, they were found to produce large microcolonies whose component cells were embedded in a very extensive matrix of polyanionic fibers that could be stabilized by reaction with antibodies to prevent collapse during the dehydration steps of preparation for electron microscopy. When these mucoid strains of P. aeruginosa were used to produce pulmonary infections of rats by the agar bead method, the infected alveoli contained large fiber-enclosed bacterial microcolonies. We conclude that the cells of P. aeruginosa that infect cystic fibrosis patients form microcolonies that are enveloped in a fibrous anionic matrix and that these microcolonies can be duplicated in in vitro cultures and in animal model systems.

Citing Articles

Echinacoside reduces intracellular c-di-GMP levels and potentiates tobramycin activity against Pseudomonas aeruginosa biofilm aggregates.

Cai Y, Hong F, De Craemer A, Malone J, Crabbe A, Coenye T NPJ Biofilms Microbiomes. 2025; 11(1):40.

PMID: 40055321 PMC: 11889090. DOI: 10.1038/s41522-025-00673-2.


Understanding Quorum-Sensing and Biofilm Forming in Anaerobic Bacterial Communities.

Markowska K, Szymanek-Majchrzak K, Pituch H, Majewska A Int J Mol Sci. 2024; 25(23).

PMID: 39684519 PMC: 11641729. DOI: 10.3390/ijms252312808.


Beyond Antibiotics: What the Future Holds.

Benyamini P Antibiotics (Basel). 2024; 13(10).

PMID: 39452186 PMC: 11504868. DOI: 10.3390/antibiotics13100919.


A 'rich-get-richer' mechanism drives patchy dynamics and resistance evolution in antibiotic-treated bacteria.

Simsek E, Kim K, Lu J, Silver A, Luo N, Lee C Mol Syst Biol. 2024; 20(8):880-897.

PMID: 38877321 PMC: 11297297. DOI: 10.1038/s44320-024-00046-5.


Intracellular : An Overlooked Reservoir in the Lungs of People with Cystic Fibrosis?.

Crabbe A Am J Respir Crit Care Med. 2024; 209(12):1421-1423.

PMID: 38498854 PMC: 11208970. DOI: 10.1164/rccm.202402-0388ED.


References
1.
DOGGETT R, Harrison G, Carter R . Mucoid Pseudomonas aeruginosa in patients with chronic illnesses. Lancet. 1971; 1(7692):236-7. DOI: 10.1016/s0140-6736(71)90973-1. View

2.
Costerton J, Ingram J, Cheng K . Structure and function of the cell envelope of gram-negative bacteria. Bacteriol Rev. 1974; 38(1):87-110. PMC: 413842. DOI: 10.1128/br.38.1.87-110.1974. View

3.
Malick L, Wilson R . Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues. Stain Technol. 1975; 50(4):265-9. DOI: 10.3109/10520297509117069. View

4.
Govan J . Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production. J Med Microbiol. 1975; 8(4):513-22. DOI: 10.1099/00222615-8-4-513. View

5.
CUNDY K, Huang N . Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families. J Pediatr. 1976; 89(1):23-6. DOI: 10.1016/s0022-3476(76)80920-1. View